Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ANEB
- Price
- 0.48
- Stock movement down
- -0.10 (-20.70%)
- Company name
- Anebulo Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 15.20M
- Ent value
- 7.64M
- Price/Sales
- -
- Price/Book
- 1.92
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -35.35%
- 1 year return (CAGR)
- -73.19%
- 3 year return (CAGR)
- -50.10%
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-03-13
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ANEB does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 1.92 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 40.78M |
| EPS (TTM) | -0.19 |
| FCF per share (TTM) | -0.14 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -9.10M |
| Net income (TTM) | -7.98M |
| EPS (TTM) | -0.19 |
| EPS (1y forward) | -0.46 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 9.04M |
| Net receivables | 56.78K |
| Total current assets | 9.27M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 9.42M |
| Accounts payable | 554.86K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 554.86K |
| Total liabilities | 1.49M |
| Shareholder's equity | 7.94M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.84M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -5.84M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -100.53% |
| Return on Assets | -84.68% |
| Return on Invested Capital | -100.53% |
| Cash Return on Invested Capital | -73.59% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.56 |
| Daily high | 0.56 |
| Daily low | 0.37 |
| Daily Volume | 3K |
| All-time high | 8.95 |
| 1y analyst estimate | 3.00 |
| Beta | -0.70 |
| EPS (TTM) | -0.19 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 7 May 2026 |
Downside potential
Loading...
Downside potential data
| ANEB | S&P500 | |
| Current price drop from All-time high | -94.63% | -1.82% |
| Highest price drop | -96.27% | -56.47% |
| Date of highest drop | 3 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -63.68% | -10.84% |
| Avg time to new high | 244 days | 12 days |
| Max time to new high | 1207 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
15.20M
Marketcap category
Small-cap
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Employees
2
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page